This happened for me, and then subsided
Download Our Free Guide on Tirzepatide and the benefits of medical weight loss
Although age-related decreases in physical activity clearly exacerbate the clinical manifestations of sarcopenia, dynapenia, and related disorders, age-related impairments in the anabolic response to feeding (i.e., anabolic resistance) [135] also likely contribute to these clinical manifestations
The most significant findings to date come from an international Phase 2 clinical trial published in 2023, which evaluated the efficacy and safety of Retatrutide in adults with obesity or overweight
On the other hand, the long duration of drug exposure in the event of serious adverse events and the flexibility of dose adjustment must be evaluated carefully
Tirzepatide, the active component in both Mounjaro and Zepbound, functions by tapping into dual-action as a GLP-1 and GIP receptor agonist